» Articles » PMID: 31011352

Administration of Vancomycin at High Doses in Patients with Post Neurosurgical Meningitis: A Comprehensive Comparison Between Continuous Infusion and Intermittent Infusion

Overview
Publisher Brieflands
Specialty Pharmacology
Date 2019 Apr 24
PMID 31011352
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Poor penetration of vancomycin into Central Nervous System (CNS) can lead to treatment failure. The aim of this study was to evaluate and compare CSF concentration and serum pharmacokinetics of high dose vancomycin by continuous infusion intermittent infusion in post neurosurgical meningitis patients. Twenty patients were divided into two groups. Patients in intermittent infusion group received vancomycin as a loading dose of 25 mg/kg over two hours, followed by 25 mg/kg over two hours every 12 h. In the Continuous Infusion group, patients received vancomycin as a loading dose of 25 mg/kg over two hours, followed by 50 mg/kg/day by continuous infusion. In the intermittent infusion group, mean ± SD of serum trough, peak and CSF concentrations were 17.49 ± 2.46 mg/L, 41.33 ± 2.73 mg/L, and 4.83 ± 1.05 mg/L, respectively. Mean of CSF/trough% ratio was 27.39 ± 2.43%. A positive linear correlation was found between the serum trough levels and CSF levels (r = 0.970, < 0.001). In continuous infusion group, mean ± SD of serum and CSF concentrations were 24.76 ± 2.02 mg/L and 6.20 ± 1.31 mg/L respectively. Mean ± SD of CSF/serum% ratio was 24.84% ± 3.54%. The serum and CSF levels revealed positive linear correlation (r = 0.902, < 0.001). The mean of CSF concentration in CI group was 6.20 ± 1.31 mg/L which was significantly higher than II group (4.83 ± 1.05 mg/L, < 0.019). CSF/serum ratio did not show any significant difference between the two groups. Continuous infusion of vancomycin makes it possible to achieve faster and constant target level in serum but did not have any significant effect on the penetration (CSF/Serum ratio) of vancomycin in to the CNS.

Citing Articles

Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections.

Liu S, Xiao J, Liu Y, Wu Y, Qi H, Wang Z Front Pharmacol. 2022; 13:1056148.

PMID: 36467047 PMC: 9718031. DOI: 10.3389/fphar.2022.1056148.


Population Pharmacokinetic Modeling and Probability of Target Attainment of Ceftaroline in Brain and Soft Tissues.

Helfer V, Zavascki A, Zeitlinger M, Araujo B, Dalla Costa T Antimicrob Agents Chemother. 2022; 66(9):e0074122.

PMID: 36005769 PMC: 9487611. DOI: 10.1128/aac.00741-22.


The CSF Vancomycin Concentration in Patients With Post-operative Intracranial Infection Can Be Predicted by the WBCs to Total Cells Ratio and the Serum Trough Concentration.

Fan M, Sun J, Sun J, Ma J, Wang N, Fang W Front Neurol. 2022; 13:893089.

PMID: 35645947 PMC: 9136157. DOI: 10.3389/fneur.2022.893089.


Efficacy of Vancomycin and Meropenem in Central Nervous System Infections in Children and Adults: Current Update.

Schneider F, Gessner A, El-Najjar N Antibiotics (Basel). 2022; 11(2).

PMID: 35203776 PMC: 8868565. DOI: 10.3390/antibiotics11020173.


Frequency Distribution of Antibiotic Therapy Intervention According to Lumbar Puncture Cerebrospinal Fluid Outcome in Hospitalized Children.

Ferdosian F, Kheyrabadi A, Nafei Z Maedica (Bucur). 2021; 15(4):454-460.

PMID: 33603902 PMC: 7879365. DOI: 10.26574/maedica.2020.15.4.454.

References
1.
Ahmed A, Jafri H, Lutsar I, McCoig C, Trujillo M, Wubbel L . Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1999; 43(4):876-81. PMC: 89220. DOI: 10.1128/AAC.43.4.876. View

2.
Kaplan S . Clinical presentations, diagnosis, and prognostic factors of bacterial meningitis. Infect Dis Clin North Am. 1999; 13(3):579-94, vi-vii. DOI: 10.1016/s0891-5520(05)70095-7. View

3.
Albanese J, Leone M, Bruguerolle B, Ayem M, Lacarelle B, Martin C . Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob Agents Chemother. 2000; 44(5):1356-8. PMC: 89870. DOI: 10.1128/AAC.44.5.1356-1358.2000. View

4.
Wysocki M, DeLatour F, Faurisson F, Rauss A, Pean Y, Misset B . Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother. 2001; 45(9):2460-7. PMC: 90678. DOI: 10.1128/AAC.45.9.2460-2467.2001. View

5.
Pfausler B, Spiss H, Beer R, Kampl A, Engelhardt K, Schober M . Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg. 2003; 98(5):1040-4. DOI: 10.3171/jns.2003.98.5.1040. View